Bullous pemphigoid in chronic lymphocytic leukemia with the demonstration of antibasement membrane antibodies.
D001323:Autoantibodies / Q000302:isolation & purification*; D001485:Basement Membrane / Q000276:immunology; D001663:Bilirubin / Q000032:analysis; D001706:Biopsy; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D002699:Chlorambucil / Q000627:therapeutic use; D004796:Clinical Enzyme Tests; D005260:Female; D005455:Fluorescent Antibody Technique; D006400:Hematocrit; D006801:Humans; D007136:Immunoglobulins / Q000302:isolation & purification; D007538:Isoniazid / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000276:immunology; D007958:Leukocyte Count; D011241:Prednisone / Q000627:therapeutic use; D011537:Pruritus / Q000150:complications; D011736:Pyridoxine / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology / Q000276:immunology* / Q000473:pathology
D001323:Autoantibodies; D001786:Blood Glucose; D007136:Immunoglobulins; D002699:Chlorambucil; D011736:Pyridoxine; D001663:Bilirubin; D007538:Isoniazid; D011241:Prednisone